"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Glucagon-like peptide-1 (GLP-1) is a hormone produced in the gut that plays a crucial role in regulating metabolism, particularly in glucose homeostasis and appetite control. It is secreted by ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Insulin lowers blood glucose by promoting its uptake into cells, while glucagon raises it by signalling ... immune interactions help control fat metabolism and obesity. This got us thinking ...

The liver and pancreas are the main actors in glucose metabolism, but not the only ones. Muscles, adipose tissue and the brain play different roles. However, the prize for the best new actor in ...

An hour of moderate-intensity exercise reduced sensations of hunger in people with overweight and obesity in a recent study.

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Insulin lowers blood glucose by promoting its uptake into cells, while glucagon raises it by signalling ... immune interactions help control fat metabolism and obesity. This got us thinking ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...